Trial Review

The ANZCTR website will be unavailable from 1pm until 3pm (AEDT) on Wednesday the 30th of October for website maintenance. Please be sure to log out of the system in order to avoid any loss of data.

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been endorsed by the ANZCTR. Before participating in a study, talk to your health care provider and refer to this information for consumers
Trial registered on ANZCTR


Registration number
ACTRN12617000562370
Ethics application status
Approved
Date submitted
19/04/2017
Date registered
21/04/2017
Date last updated
11/03/2020
Date data sharing statement initially provided
11/03/2020
Type of registration
Prospectively registered

Titles & IDs
Public title
A comparison of arterial and blood gas analyses in sleep studies
Scientific title
GAS (Gas Analysis in Sleep) study: a comparison of arterial and venous blood gas analyses in sleep study participants
CapGAS substudy: a comparison of arterial and capillary blood gas analyses in sleep study participants
Secondary ID [1] 291655 0
Nil known
Universal Trial Number (UTN)
U1111-1195-2949
Trial acronym
GAS Study
Linked study record
None

Health condition
Health condition(s) or problem(s) studied:
Hypoventilation 302810 0
Condition category
Condition code
Respiratory 302304 302304 0 0
Other respiratory disorders / diseases
Respiratory 302305 302305 0 0
Sleep apnoea

Intervention/exposure
Study type
Interventional
Description of intervention(s) / exposure
A venous blood gas will be taken as paired with each arterial blood gas (generally two per patient in a one night sleep study at the commencement and end of the study). Transcutaneous measurements of CO2, if taken as part of the sleep study, will also be recorded, along with the time between blood samples and relevant personal information.

In the ethics-approved substudy, on completion of enrolment for venous and arterial blood gas comparisons, further participants will be recruited to compare capillary and arterial blood gases. Information on patient preference on sampling technique is recorded.
Intervention code [1] 297741 0
Diagnosis / Prognosis
Comparator / control treatment
The study compares the values obtained from venous and arterial blood gas measurements and non-invasive percutaneous measurements. Each patient provides both "treatment" and "control" data.
Control group
Active

Outcomes
Primary outcome [1] 301713 0
Relationship between arterial and venous blood gas carbon dioxide tensions in terms of absolute and relative bias (a composite outcome). This is assessed statistically by comparing the values from arterial and venous blood gases. In the independently-analysed CapGAS substudy the comparison will be between capillary and arterial blood gases.
Timepoint [1] 301713 0
At the time blood gases would otherwise be taken for the sleep study, which is generally at the start of the study (before sleep) and the end of the study (upon waking in the morning).
Primary outcome [2] 301833 0
Relationship between arterial and venous blood gas carbon dioxide tensions in terms of a Bland-Altman plot and 95% limits of agreement. This is assessed statistically by comparing the values from arterial and venous blood gases. In the independently-analysed CapGAS substudy the comparison will be between capillary and venous blood gases.
Timepoint [2] 301833 0
At the time blood gases would otherwise be taken for the sleep study, which is generally at the start of the study (before sleep) and the end of the study (upon waking in the morning).
Secondary outcome [1] 333656 0
Comparison of the difference of (percutaneous carbon dioxide vs venous carbon dioxide measurements) and (percutaneous carbon dioxide vs arterial carbon dioxide measurements) as a single endpoint. This is assessed statistically by comparing the values from arterial and venous blood gases and the percutaneous carbon dioxide measurement recorded at the time of taking the blood gases. In the CapGAS substudy, capillary samples replace venous samples.
Timepoint [1] 333656 0
At the time blood gases would otherwise be taken for the sleep study, which is generally at the start of the study (before sleep) and the end of the study (upon waking in the morning).
Secondary outcome [2] 333959 0
Data modelling to illustrate any evident consistent relationships between venous and ABG pCO2 when measured twice in the same patient over the course of the sleep study.
Timepoint [2] 333959 0
At the time blood gases would otherwise be taken for the sleep study, which is generally at the start of the study (before sleep) and the end of the study (upon waking in the morning).
Secondary outcome [3] 333978 0
Data modelling to illustrate how the pvCO2-paCO2 relationship is affected by pH, haemoglobin, oxygen saturation, bicarbonate or a combination of these.
Timepoint [3] 333978 0
At the time blood gases would otherwise be taken for the sleep study, which is generally at the start of the study (before sleep) and the end of the study (upon waking in the morning).
Secondary outcome [4] 333979 0
Relationship between arterial and venous blood gas pH in terms of a Bland-Altman plot and 95% limits of agreement. This is assessed statistically by comparing the values from arterial and venous blood gases.
Timepoint [4] 333979 0
At the time blood gases would otherwise be taken for the sleep study, which is generally at the start of the study (before sleep) and the end of the study (upon waking in the morning).
Secondary outcome [5] 333980 0
Relationship between arterial and venous blood gas pH in terms of absolute and relative bias (a composite outcome). This is assessed statistically by comparing the values from arterial and venous blood gases.
Timepoint [5] 333980 0
At the time blood gases would otherwise be taken for the sleep study, which is generally at the start of the study (before sleep) and the end of the study (upon waking in the morning).
Secondary outcome [6] 381127 0
To determine if capillary blood gas samples can be obtained more consistently than ABG samples and the time required to obtain a successful CAPgas or ABG.
Timepoint [6] 381127 0
At the time blood gases would otherwise be taken for the sleep study, which is generally at the start of the study (before sleep) and the end of the study (upon waking in the morning).
Secondary outcome [7] 381128 0
To compare patient pain with arterial and capillary blood gas sampling using a rating scale.
Timepoint [7] 381128 0
To compare operator preference between arterial and capillary blood gas sampling.

Eligibility
Key inclusion criteria
Patients having a diagnostic, continuous positive airway pressure (CPAP) or ventilation sleep study which includes arterial blood gas analysis.
Minimum age
18 Years
Maximum age
No limit
Sex
Both males and females
Can healthy volunteers participate?
No
Key exclusion criteria
Pregnancy, inability to consent, outside age group

Study design
Purpose of the study
Diagnosis
Allocation to intervention
Randomised controlled trial
Procedure for enrolling a subject and allocating the treatment (allocation concealment procedures)
The trial is randomised only as to the order of ABG and VBG collection, but participants are not randomised to a control group [there was no option above]. Patients will be allocated by sealed-envelope selection. Envelopes will be opaque and shuffled as well as is practicable.
Methods used to generate the sequence in which subjects will be randomised (sequence generation)
Envelopes will be opaque and shuffled as well as is practicable.
Masking / blinding
Open (masking not used)
Who is / are masked / blinded?



Intervention assignment
Crossover
Other design features
Blinding will not be practicible.
Phase
Not Applicable
Type of endpoint/s
Statistical methods / analysis
Paired analysis of arterial and venous/capillary samples is to be made for carbon dioxide tension, pH, oxygen tension, oxygen saturation and total haemoglobin (as a marker of variability) by methods for testing measures. Correlation coefficients will be examined.

Recruitment
Recruitment status
Completed
Date of first participant enrolment
Anticipated
1/05/2017
Actual
28/06/2017
Date of last participant enrolment
Anticipated
7/07/2017
Actual
30/04/2019
Date of last data collection
Anticipated
8/07/2017
Actual
1/05/2019
Sample size
Target
141
Accrual to date
Final
142
Recruitment in Australia
Recruitment state(s)
VIC
Recruitment hospital [1] 7816 0
Austin Health - Austin Hospital - Heidelberg
Recruitment postcode(s) [1] 15749 0
3084 - Heidelberg

Funding & Sponsors
Funding source category [1] 296155 0
Hospital
Name [1] 296155 0
Austin Hospital
Country [1] 296155 0
Australia
Funding source category [2] 296156 0
Other Collaborative groups
Name [2] 296156 0
Institute for Breathing and Sleep
Country [2] 296156 0
Australia
Primary sponsor type
Hospital
Name
Austin Hospital
Address
145 Studley Rd, Heidelberg VIC 3084
Country
Australia
Secondary sponsor category [1] 295056 0
Other Collaborative groups
Name [1] 295056 0
Institute for Breathing and Sleep
Address [1] 295056 0
145 Studley Rd, Heidelberg VIC 3084
Country [1] 295056 0
Australia

Ethics approval
Ethics application status
Approved
Ethics committee name [1] 297402 0
Austin Health Human Research Ethics Committee
Ethics committee address [1] 297402 0
Ethics committee country [1] 297402 0
Australia
Date submitted for ethics approval [1] 297402 0
16/10/2016
Approval date [1] 297402 0
31/03/2017
Ethics approval number [1] 297402 0
HREC/16/Austin/441

Summary
Brief summary
Trial website
Trial related presentations / publications
Public notes

Contacts
Principal investigator
Name 73926 0
Prof Christine McDonald
Address 73926 0
Austin Health
145 Studley Rd, Heidelberg VIC 3084
Country 73926 0
Australia
Phone 73926 0
+61394965000
Fax 73926 0
Email 73926 0
[email protected]
Contact person for public queries
Name 73927 0
Christine McDonald
Address 73927 0
Austin Health
145 Studley Rd, Heidelberg VIC 3084
Country 73927 0
Australia
Phone 73927 0
+61394965000
Fax 73927 0
Email 73927 0
[email protected]
Contact person for scientific queries
Name 73928 0
Steven Lindstrom
Address 73928 0
Austin Health
145 Studley Rd, Heidelberg VIC 3084
Country 73928 0
Australia
Phone 73928 0
+61394965000
Fax 73928 0
Email 73928 0
[email protected]

Data sharing statement
Will individual participant data (IPD) for this trial be available (including data dictionaries)?
No
No/undecided IPD sharing reason/comment
Some data collected prior to 25th October 2018.


What supporting documents are/will be available?

No Supporting Document Provided



Results publications and other study-related documents

Documents added manually
No documents have been uploaded by study researchers.

Documents added automatically
No additional documents have been identified.